【默达生物获上亿元人民币A轮融资】深圳默达生物科技有限公司（META Pharmaceuticals Inc.）近日宣布完成上亿元人民币的A轮融资。本轮融资由Forcefield Ventures、晶泰科技、IMO Ventures和天图资本领投，方圆资本、德迅投资、雅亿资本、新产业创投和博普资本等跟投。

金融界2025-02-18

深圳默达生物科技有限公司（META Pharmaceuticals Inc.）近日宣布完成上亿元人民币的A轮融资。本轮融资由Forcefield Ventures、晶泰科技、IMO Ventures和天图资本领投，方圆资本、德迅投资、雅亿资本、新产业创投和博普资本等跟投。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2512249902?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-18 11:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2512249902","market":"us","top_or_hot":-1,"title":"【默达生物获上亿元人民币A轮融资】深圳默达生物科技有限公司（META Pharmaceuticals Inc.）近日宣布完成上亿元人民币的A轮融资。本轮融资由Forcefield Ventures、晶泰科技、IMO Ventures和天图资本领投，方圆资本、德迅投资、雅亿资本、新产业创投和博普资本等跟投。","media":"金融界","content":"<div>\n<p>深圳默达生物科技有限公司（META Pharmaceuticals Inc.）近日宣布完成上亿元人民币的A轮融资。本轮融资由Forcefield Ventures、晶泰科技、IMO Ventures和天图资本领投，方圆资本、德迅投资、雅亿资本、新产业创投和博普资本等跟投。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/02/18112348218626.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【默达生物获上亿元人民币A轮融资】深圳默达生物科技有限公司（META Pharmaceuticals Inc.）近日宣布完成上亿元人民币的A轮融资。本轮融资由Forcefield Ventures、晶泰科技、IMO Ventures和天图资本领投，方圆资本、德迅投资、雅亿资本、新产业创投和博普资本等跟投。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【默达生物获上亿元人民币A轮融资】深圳默达生物科技有限公司（META Pharmaceuticals Inc.）近日宣布完成上亿元人民币的A轮融资。本轮融资由Forcefield Ventures、晶泰科技、IMO Ventures和天图资本领投，方圆资本、德迅投资、雅亿资本、新产业创投和博普资本等跟投。\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-18 11:23 北京时间&nbsp;&nbsp;&nbsp;<a href=https://24h.jrj.com.cn/2025/02/18112348218626.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>深圳默达生物科技有限公司（META Pharmaceuticals Inc.）近日宣布完成上亿元人民币的A轮融资。本轮融资由Forcefield Ventures、晶泰科技、IMO Ventures和天图资本领投，方圆资本、德迅投资、雅亿资本、新产业创投和博普资本等跟投。</p>\n\n<a href=\"https://24h.jrj.com.cn/2025/02/18112348218626.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BJTD4V19.USD","symbol_name":"NEUBERGER BERMAN US LONG SHORT EQUITY \"A1\" (USD) ACC","start_time":0,"source_url":"https://24h.jrj.com.cn/2025/02/18112348218626.shtml","article_id":"2512249902","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2512249902","pubTimestamp":1739849027,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"深圳默达生物科技有限公司（META Pharmaceuticals Inc.）近日宣布完成上亿元人民币的A轮融资。本轮融资由Forcefield Ventures、晶泰科技、IMO Ventures和天图资本领投，方圆资本、德迅投资、雅亿资本、新产业创投和博普资本等跟投。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159837":"生物科技","300832":"新产业","IE00BJTD4V19.USD":"NEUBERGER BERMAN US LONG SHORT EQUITY \"A1\" (USD) ACC","LU0878866978.SGD":"First Eagle Amundi International AHS-QD SGD-H","LU1642822529.SGD":"THREADNEEDLE (LUX) GLOBAL TECHNOLOGY \"A\" (SGD) ACC","LU0795875169.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD-H","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","LU2430703251.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (USD) INC","LU0082616367.USD":"摩根大通美国科技A（dist）","LU2213496289.HKD":"ALLIANZ INCOME AND GROWTH \"AT\" (HKD) ACC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","02228":"晶泰控股","LU0353189680.USD":"富国美国全盘成长基金Cl A Acc","LU1732799900.SGD":"JPMorgan Investment Funds - Global Income A (irc) SGD-H","LU1814569148.SGD":"WELLINGTON GLOBAL QUALITY GROWTH \"D\" (SGDHDG) ACC","LU0949170772.SGD":"Blackrock Global Equity Income A6 SGD-H","SG9999014898.SGD":"United Global Quality Growth Fund Dis SGD","LU2764262908.HKD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (HKD) ACC","LU0157215616.USD":"FIDELITY GLOBAL FOCUS \"A\" INC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU0109391861.USD":"富兰克林美国机遇基金A Acc","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","LU0553294199.USD":"BGF GLOBAL EQUITY INCOME \"A5G\" (USD) INC","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","SGXZ99366536.SGD":"United Global Innovation A Acc SGD-H","LU1127390331.HKD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"A\" (HKD) ACC","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","LU0545039389.USD":"BGF GLOBAL EQUITY INCOME \"A2\" ACC","LU0011850046.USD":"贝莱德全球长线股票 A2 USD","IMO":"帝国石油","GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC","BK4592":"伊斯兰概念","IE00BK4W5M84.HKD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (HKD) ACC","LU2462157665.USD":"ALLIANZ GLOBAL INCOME \"A\" (USD) INC","IE00B7KXQ091.USD":"Janus Henderson Balanced A Inc USD","LU0097036916.USD":"贝莱德美国增长A2 USD","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","IE00B4JS1V06.HKD":"JANUS HENDERSON BALANCED \"A2\" (HKD) ACC","LU0345769128.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) ACC","BK0239":"医药制造","LU2720916845.USD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (USD) ACC","LU1852331112.SGD":"Blackrock World Technology Fund A2 SGD-H","LU0225283273.USD":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC","LU0234572021.USD":"高盛美国核心股票组合Acc","SGXZ31699556.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"C\" (SGDHDG) ACC","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC"},"translate_title":"[META Biotech received hundreds of millions of yuan in Series A financing] Shenzhen META Biotechnology Co., Ltd. (META Pharmaceuticals Inc.) recently announced the completion of hundreds of millions of yuan in Series A financing. This round of financing was led by Forcefield Ventures, Jingtai Technology, IMO Ventures and Tiantu Capital, followed by Fangyuan Capital, Dexun Investment, Yayi Capital, New Industry Venture Capital and Bopu Capital.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159837":1,"300832":1,"IMO":1,"02228":1},"content_text":"深圳默达生物科技有限公司（META Pharmaceuticals Inc.）近日宣布完成上亿元人民币的A轮融资。本轮融资由Forcefield Ventures、晶泰科技、IMO Ventures和天图资本领投，方圆资本、德迅投资、雅亿资本、新产业创投和博普资本等跟投。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2512249902","isCrawlerRequest":true}